Comments
Loading...

BioNTech Analyst Ratings

BNTXNASDAQ
Logo brought to you by Benzinga Data
$106.53
2.132.04%
At close: -
$106.53
0.000.00%
After Hours: 4:03 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$171.44
Lowest Price Target1
$110.00
Consensus Price Target1
$140.61

BioNTech Analyst Ratings and Price Targets | NASDAQ:BNTX | Benzinga

BioNTech Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for BioNTech Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jan
4
Mar
1
Apr
4
2
May
3
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Truist Securities
Goldman Sachs
JP Morgan
Citigroup

1calculated from analyst ratings

Analyst Ratings for BioNTech

Buy NowGet Alert
06/16/2025Buy Now—HC Wainwright & Co.
Robert Burns45%
$145 → $138MaintainsBuyGet Alert
06/05/2025Buy Now—HC Wainwright & Co.
Robert Burns45%
$134 → $145MaintainsBuyGet Alert
06/03/2025Buy Now—Truist Securities
Asthika Goonewardene43%
$151 → $155ReiteratesBuy → BuyGet Alert
05/29/2025Buy Now—Goldman Sachs
Asad Haider 58%
→ $110Initiates → NeutralGet Alert
05/22/2025Buy Now—JP Morgan
Jessica Fye67%
$120 → $116MaintainsNeutralGet Alert
05/22/2025Buy Now—HC Wainwright & Co.
Robert Burns45%
$134 → $134ReiteratesBuy → BuyGet Alert
05/14/2025Buy Now—HC Wainwright & Co.
Robert Burns45%
$145 → $134MaintainsBuyGet Alert
05/06/2025Buy Now—Citigroup
Geoff Meacham63%
$145 → $140MaintainsBuyGet Alert
05/06/2025Buy Now—Morgan Stanley
Terence Flynn65%
$140 → $132MaintainsOverweightGet Alert
04/01/2025Buy Now—HC Wainwright & Co.
Robert Burns45%
$150 → $145MaintainsBuyGet Alert
03/13/2025Buy Now—Citigroup
Geoff Meacham63%
→ $145Initiates → BuyGet Alert
03/11/2025Buy Now—Morgan Stanley
Terence Flynn65%
$145 → $139MaintainsOverweightGet Alert
03/11/2025Buy Now—Canaccord Genuity
John Newman45%
$171.44 → $171.44MaintainsBuyGet Alert
03/11/2025Buy Now—BMO Capital
Etzer Darout48%
$130 → $143MaintainsOutperformGet Alert
01/10/2025Buy Now—Truist Securities
Asthika Goonewardene43%
→ $172Initiates → BuyGet Alert
12/11/2024Buy Now—Wells Fargo
Mohit Bansal67%
→ $170Initiates → OverweightGet Alert
11/27/2024Buy Now—Canaccord Genuity
William Maughan71%
$171 → $171.44MaintainsBuyGet Alert
11/26/2024Buy Now—JP Morgan
Jessica Fye67%
$124 → $122MaintainsNeutralGet Alert
11/19/2024Buy Now—Evercore ISI Group
Cory Kasimov67%
$110 → $125UpgradeIn-Line → OutperformGet Alert
11/18/2024Buy Now—Canaccord Genuity
John Newman45%
$171 → $171MaintainsBuyGet Alert
11/18/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$150 → $150ReiteratesBuy → BuyGet Alert
11/14/2024Buy Now—Canaccord Genuity
John Newman45%
$171 → $171MaintainsBuyGet Alert
11/08/2024Buy Now—Goldman Sachs
Chris Shibutani54%
$90 → $137UpgradeNeutral → BuyGet Alert
11/06/2024Buy Now—TD Cowen
Yaron Werber36%
$132 → $122MaintainsHoldGet Alert
11/05/2024Buy Now—TD Cowen
Yaron Werber36%
$132 → $122MaintainsHoldGet Alert
11/04/2024Buy Now—JP Morgan
Jessica Fye67%
$125 → $124MaintainsNeutralGet Alert
10/07/2024Buy Now—HSBC
Yifeng Liu35%
$97 → $136MaintainsBuyGet Alert
10/07/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$113 → $150MaintainsBuyGet Alert
09/24/2024Buy Now—Morgan Stanley
Terence Flynn65%
$93 → $145UpgradeEqual-Weight → OverweightGet Alert
09/19/2024Buy Now—Deutsche Bank
Emmanuel Papadakis39%
$95 → $150MaintainsBuyGet Alert
09/18/2024Buy Now—UBS
Eliana Merle48%
$97 → $131MaintainsNeutralGet Alert
09/17/2024Buy Now—Jefferies
Akash Tewari43%
$96 → $150UpgradeHold → BuyGet Alert
09/16/2024Buy Now—JP Morgan
Jessica Fye67%
$91 → $125UpgradeUnderweight → NeutralGet Alert
09/16/2024Buy Now—B of A Securities
Tazeen Ahmad57%
$125 → $150MaintainsBuyGet Alert
09/16/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$113 → $113ReiteratesBuy → BuyGet Alert
09/13/2024Buy Now—Jefferies
Akash Tewari43%
$90 → $96MaintainsHoldGet Alert
08/27/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$113 → $113ReiteratesBuy → BuyGet Alert
08/19/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$113 → $113ReiteratesBuy → BuyGet Alert
08/15/2024Buy Now—JP Morgan
Jessica Fye67%
$94 → $91MaintainsUnderweightGet Alert
08/07/2024Buy Now—Deutsche Bank
Emmanuel Papadakis39%
$95 → $95UpgradeHold → BuyGet Alert
08/06/2024Buy Now—TD Cowen
Yaron Werber36%
$98 → $85MaintainsHoldGet Alert
08/01/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$113 → $113ReiteratesBuy → BuyGet Alert
06/26/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$113 → $113ReiteratesBuy → BuyGet Alert
06/12/2024Buy Now—JP Morgan
Jessica Fye67%
$90 → $94MaintainsUnderweightGet Alert
06/10/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$113 → $113ReiteratesBuy → BuyGet Alert
06/04/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$113 → $113ReiteratesBuy → BuyGet Alert
06/03/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$113 → $113ReiteratesBuy → BuyGet Alert
05/30/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$113 → $113ReiteratesBuy → BuyGet Alert
05/28/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$113 → $113ReiteratesBuy → BuyGet Alert
05/24/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$113 → $113ReiteratesBuy → BuyGet Alert
05/14/2024Buy Now—Evercore ISI Group
Cory Kasimov67%
→ $100Initiates → In-LineGet Alert
05/08/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$107 → $113MaintainsBuyGet Alert
05/07/2024Buy Now—TD Cowen
Yaron Werber36%
$95 → $98MaintainsHoldGet Alert
05/07/2024Buy Now—BMO Capital
Etzer Darout48%
$123 → $122MaintainsOutperformGet Alert
04/17/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$107 → $107ReiteratesBuy → BuyGet Alert
03/27/2024Buy Now—UBS
Eliana Merle48%
$110 → $101MaintainsNeutralGet Alert
03/22/2024Buy Now—JP Morgan
Jessica Fye67%
$99 → $90MaintainsUnderweightGet Alert
03/21/2024Buy Now—Canaccord Genuity
John Newman45%
$171 → $171ReiteratesBuy → BuyGet Alert
03/21/2024Buy Now—BMO Capital
Etzer Darout48%
$127 → $123MaintainsOutperformGet Alert
02/28/2024Buy Now—Goldman Sachs
Chris Shibutani54%
$113 → $100MaintainsNeutralGet Alert
02/23/2024Buy Now—Canaccord Genuity
John Newman45%
$171 → $171ReiteratesBuy → BuyGet Alert
02/23/2024Buy Now—BMO Capital
Etzer Darout48%
→ $127Initiates → OutperformGet Alert
02/21/2024Buy Now—Canaccord Genuity
John Newman45%
$171 → $171ReiteratesBuy → BuyGet Alert
02/20/2024Buy Now—Canaccord Genuity
John Newman45%
$168 → $171MaintainsBuyGet Alert
01/23/2024Buy Now—HC Wainwright & Co.
Robert Burns45%
$133 → $107MaintainsBuyGet Alert
12/01/2023Buy Now—JP Morgan
Jessica Fye67%
$106 → $99DowngradeNeutral → UnderweightGet Alert
11/27/2023Buy Now—HC Wainwright & Co.
Robert Burns45%
→ $133ReiteratesBuy → BuyGet Alert
11/14/2023Buy Now—HC Wainwright & Co.
Robert Burns45%
$180 → $133MaintainsBuyGet Alert
11/08/2023Buy Now—Morgan Stanley
Matthew Korn45%
$110 → $111MaintainsEqual-WeightGet Alert
10/17/2023Buy Now—Morgan Stanley
Matthew Korn45%
$116 → $110MaintainsEqual-WeightGet Alert
10/16/2023Buy Now—HSBC
Yifeng Liu35%
$124 → $111DowngradeBuy → HoldGet Alert
08/28/2023Buy Now—HC Wainwright & Co.
Robert Burns45%
→ $180ReiteratesBuy → BuyGet Alert
08/10/2023Buy Now—HC Wainwright & Co.
Robert Burns45%
$181 → $180MaintainsBuyGet Alert
08/08/2023Buy Now—Morgan Stanley
Matthew Korn45%
$119 → $116MaintainsEqual-WeightGet Alert
08/01/2023Buy Now—Morgan Stanley
Matthew Korn45%
$119 → $119ReiteratesEqual-Weight → Equal-WeightGet Alert
07/31/2023Buy Now—Morgan Stanley
Matthew Korn45%
$119 → $119ReiteratesEqual-Weight → Equal-WeightGet Alert
07/24/2023Buy Now—Morgan Stanley
Matthew Korn45%
$119 → $119ReiteratesEqual-Weight → Equal-WeightGet Alert
07/17/2023Buy Now—Morgan Stanley
Matthew Korn45%
$119 → $119ReiteratesEqual-Weight → Equal-WeightGet Alert
07/14/2023Buy Now—HSBC
Rajesh Kumar61%
→ $124Initiates → BuyGet Alert
07/11/2023Buy Now—Morgan Stanley
Matthew Korn45%
$124 → $119MaintainsEqual-WeightGet Alert
06/26/2023Buy Now—Morgan Stanley
Matthew Korn45%
$124 → $124ReiteratesEqual-Weight → Equal-WeightGet Alert
06/20/2023Buy Now—Morgan Stanley
Matthew Korn45%
→ $124ReiteratesEqual-Weight → Equal-WeightGet Alert
06/16/2023Buy Now—Canaccord Genuity
John Newman45%
$203 → $203ReiteratesBuy → BuyGet Alert
06/12/2023Buy Now—Morgan Stanley
Matthew Korn45%
→ $124Reiterates → Equal-WeightGet Alert
06/09/2023Buy Now—HC Wainwright & Co.
Robert Burns45%
→ $181Reiterates → BuyGet Alert
06/01/2023Buy Now—HC Wainwright & Co.
Robert Burns45%
$198 → $181MaintainsBuyGet Alert
05/23/2023Buy Now—HC Wainwright & Co.
Robert Burns45%
$210 → $198MaintainsBuyGet Alert
05/18/2023Buy Now—Deutsche Bank
Emmanuel Papadakis39%
$135 → $120MaintainsHoldGet Alert
05/17/2023Buy Now—Redburn Partners
Simon Baker26%
$165 → $170UpgradeNeutral → BuyGet Alert
05/09/2023Buy Now—Morgan Stanley
Matthew Korn45%
$150 → $124MaintainsEqual-WeightGet Alert
04/24/2023Buy Now—Deutsche Bank
Emmanuel Papadakis39%
$160 → $135MaintainsHoldGet Alert
04/10/2023Buy Now—JP Morgan
Jessica Fye67%
$142 → $128MaintainsNeutralGet Alert
03/31/2023Buy Now—UBS
Eliana Merle48%
$168 → $153MaintainsNeutralGet Alert
03/30/2023Buy Now—HC Wainwright & Co.
Robert Burns45%
→ $210Reiterates → BuyGet Alert
03/28/2023Buy Now—Canaccord Genuity
William Maughan71%
$191 → $203MaintainsBuyGet Alert
03/28/2023Buy Now—TD Cowen
Yaron Werber36%
$145 → $130MaintainsMarket PerformGet Alert
03/28/2023Buy Now—B of A Securities
Tazeen Ahmad57%
$239 → $194MaintainsBuyGet Alert
03/28/2023Buy Now—Morgan Stanley
Matthew Korn45%
$216 → $150MaintainsEqual-WeightGet Alert
03/28/2023Buy Now—Goldman Sachs
Chris Shibutani54%
$156 → $140MaintainsNeutralGet Alert
03/23/2023Buy Now—HC Wainwright & Co.
Robert Burns45%
$272 → $210MaintainsBuyGet Alert

FAQ

Q

What is the target price for BioNTech (BNTX) stock?

A

The latest price target for BioNTech (NASDAQ:BNTX) was reported by HC Wainwright & Co. on June 16, 2025. The analyst firm set a price target for $138.00 expecting BNTX to rise to within 12 months (a possible 29.54% upside). 43 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for BioNTech (BNTX)?

A

The latest analyst rating for BioNTech (NASDAQ:BNTX) was provided by HC Wainwright & Co., and BioNTech maintained their buy rating.

Q

When was the last upgrade for BioNTech (BNTX)?

A

The last upgrade for BioNTech SE happened on November 19, 2024 when Evercore ISI Group raised their price target to $125. Evercore ISI Group previously had an in-line for BioNTech SE.

Q

When was the last downgrade for BioNTech (BNTX)?

A

The last downgrade for BioNTech SE happened on December 1, 2023 when JP Morgan changed their price target from $106 to $99 for BioNTech SE.

Q

When is the next analyst rating going to be posted or updated for BioNTech (BNTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioNTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioNTech was filed on June 16, 2025 so you should expect the next rating to be made available sometime around June 16, 2026.

Q

Is the Analyst Rating BioNTech (BNTX) correct?

A

While ratings are subjective and will change, the latest BioNTech (BNTX) rating was a maintained with a price target of $145.00 to $138.00. The current price BioNTech (BNTX) is trading at is $106.53, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch